Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Lemmin

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Immunological Reviews|January 31, 2017
Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1Peter D Kwong, Gwo-Yu Chuang, Brandon J DeKosky, et al.
Nature Chemistry|August 25, 2017
A 31-residue peptide induces aggregation of tau's microtubule-binding region in cellsJan Stöhr, Haifan Wu, Mimi Nick, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's diseaseCarlo Condello, Thomas Lemmin, Jan Stöhr, et al.
Nature Communications|November 19, 2021
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralizationNikolas Friedrich, Emanuel Stiegeler, Matthias Glögl, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2017
XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conductionJessica L Thomaston, Rahel A Woldeyes, Takanori Nakane, et al.
Nature Structural & Molecular Biology|August 21, 2023
Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralizationMatthias Glögl, Nikolas Friedrich, Gabriele Cerutti, et al.
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Nature Medicine|June 6, 2018
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1Kai Xu, Priyamvada Acharya, Rui Kong, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Immunological Reviews|January 31, 2017
Antibodyomics: bioinformatics technologies for understanding B-cell immunity to HIV-1Peter D Kwong, Gwo-Yu Chuang, Brandon J DeKosky, et al.
Nature Chemistry|August 25, 2017
A 31-residue peptide induces aggregation of tau's microtubule-binding region in cellsJan Stöhr, Haifan Wu, Mimi Nick, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's diseaseCarlo Condello, Thomas Lemmin, Jan Stöhr, et al.
Nature Communications|November 19, 2021
Distinct conformations of the HIV-1 V3 loop crown are targetable for broad neutralizationNikolas Friedrich, Emanuel Stiegeler, Matthias Glögl, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2017
XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conductionJessica L Thomaston, Rahel A Woldeyes, Takanori Nakane, et al.
Nature Structural & Molecular Biology|August 21, 2023
Trapping the HIV-1 V3 loop in a helical conformation enables broad neutralizationMatthias Glögl, Nikolas Friedrich, Gabriele Cerutti, et al.
Science (New York, N.Y.)|May 14, 2016
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyRui Kong, Kai Xu, Tongqing Zhou, et al.
Cell|April 27, 2016
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GGuillaume B E Stewart-Jones, Cinque Soto, Thomas Lemmin, et al.
Cell Reports|April 27, 2017
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody ElicitationTongqing Zhou, Nicole A Doria-Rose, Cheng Cheng, et al.
Nature Medicine|June 6, 2018
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1Kai Xu, Priyamvada Acharya, Rui Kong, et al.
Pageof 5